Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03041324
Recruitment Status : Active, not recruiting
First Posted : February 2, 2017
Last Update Posted : July 2, 2019
Sponsor:
Information provided by (Responsible Party):
Sangamo Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 2021
  Estimated Study Completion Date : February 2022